ArticleScientific reports2024

Machine learning using clinical data at baseline predicts the medium-term efficacy of ustekinumab in patients with ulcerative colitis.

Hiromu Morikubo et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.